NYSE:CORHealthcare
Is It Too Late To Consider Cencora After Its Strong 2025 Share Price Rally?
If you are wondering whether Cencora is still worth buying after such a strong run, or if the prudent move now is to wait for a better entry price, you are in the right place.
The stock has pulled back around 6.5% over the last month, but is still up 51.6% year to date and about 48.1% over the past year, which keeps the long term uptrend very much intact.
Recent headlines have focused on Cencora's ongoing role in streamlining pharmaceutical distribution and expanding its specialty services...